IEX •
Healthcare •
Biotechnology •
Quote as of 05/27/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization23.05 mln
Float15.79 mln
Earnings Date05/12/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-147
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Hoth Therapeutics is a New York-based biopharmaceutical company founded in 2017 that focuses on creating new treatments for conditions that currently lack effective solutions. Its pipeline covers a broad range of medical areas, including skin disorders, brain injuries, cancer, Alzheimer's disease, lupus, asthma, and allergies, with several candidates already in clinical trials. The company builds on partnerships with leading universities and biotech firms to advance its proprietary drug platforms toward patients in need.
